Aster DM Healthcare Limited (ASTERDM) — Announcement Announcement

StockFin.ai Try Free →

📢 Key Event
Aster DM Healthcare announces merger with QCIL to create a combined healthcare entity with 10,623 beds and INR 9,273 Cr revenue.

🔄 What Changed
Combined entity formed with 10,623 beds and INR 9,273 Cr revenue; 45% premium valuation for Aster

🔮 What's Next
Q1 FY27 merger closing deadline; 4,445 beds to be added by FY30 targeting 15,068 total beds

💡 Investor Takeaway
The merger creates a larger, more profitable healthcare platform with significant growth potential for shareholders through scale and expansion.

Aster DM Healthcare Limited announced its merger with Quality Care India Limited, creating a combined entity with 10,623 beds and INR 9,273 Cr revenue, targeting INR 2,013 Cr operating EBITDA by FY26. The merger, approved by 96.68% shareholders, will close in Q1 FY27 and includes a 45% premium valuation for Aster. Expansion plans add 4,445 beds by FY30, targeting 15,068 total beds, while FY26 revenue grew 16% YoY to INR 4,643 Cr with 20.4% operating EBITDA margin. The transaction enhances scale, diversification, and growth potential across 9 states and 28 cities.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ASTERDM ✨ Ask AI About This

About Aster DM Healthcare Limited (ASTERDM)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹39,048.19 Cr P/E: 7.1

View full ASTERDM stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Aster DM Healthcare Limited (ASTERDM) — Announcement Announcement

About Aster DM Healthcare Limited (ASTERDM)

Recent Announcements from Aster DM Healthcare Limited